Paola Mazzanti

Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma

Lory Santarelli, Elisabetta Strafella, Sara Staffolani et al. · PLoS ONE · 2011 · 110 citations · Full text

Role of maspin in cancer

Rossana Berardi, Francesca Morgese, Azzurra Onofri et al. · Clinical and Translational Medicine · 2013 · 109 citations · Full text

Oncology, Medicine, Cancer Growth +12

Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer

Paola Mazzanti, Cristian Massacesi, Marco Rocchi et al. · Lung Cancer · 2003 · 74 citations

Medicine, Phase Ii Study, Bronchial Neoplasm +7

CISCA (cisplatin vs. carboplatin) meta-analysis: An individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC)

Andrea Ardizzoni, Marcello Tiseo, Luca Boni et al. · Journal of Clinical Oncology · 2006 · 62 citations

Carboplatin-based Chemotherapy, Clinical Endpoint, First-line Treatment +16

Performance at Preoperative Stair-Climbing Test Is Associated With Prognosis After Pulmonary Resection in Stage I Non-Small Cell Lung Cancer

Alessandro Brunelli, Cecilia Pompili, Rossana Berardi et al. · The Annals of Thoracic Surgery · 2012 · 56 citations · Full text

Surgical Oncology, Interventional Pulmonology, Medicine +11